Aktie SUDARSHAN SUDARSHAN PHARMA INDUSTRIES LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Sudarshan Pharma Industries Limited

Aktien

SUDARSHAN

INE00TV01015

SUDARSHAN

Markt geschlossen - Bombay S.E.
Andere Börsenplätze
 12:00:51 17.05.2024 		% 5 Tage % 1. Jan.
69 INR +5,23 % Intraday Chart für Sudarshan Pharma Industries Limited -1,32 % -15,12 %
01.04. Sudarshan Pharma Industries Limited kündigt den Rücktritt von Ishita Samani als Company Secretary und Compliance Officer an CI
2023 Sudarshan Pharma Industries Limited gibt den Rücktritt von Nilesh Thakkar als zusätzlicher Direktor bekannt CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Sudarshan Pharma Industries Limited Announces Resignation of Ishita Samani as Company Secretary and Compliance Officer
1,165,368 Equity Shares of Sudarshan Pharma Industries Limited are subject to a Lock-Up Agreement Ending on 30-MAR-2024.
11,224,937 Equity Shares of Sudarshan Pharma Industries Limited are subject to a Lock-Up Agreement Ending on 29-MAR-2024.
Sudarshan Pharma Industries Limited Appoints Sachin Mehta as the Chief Financial Officer, Effective December 12, 2023
Sudarshan Pharma Industries Limited Announces Resignation of Nilesh Thakkar as Additional Director
Sudarshan Pharma Industries Limited Announces Board Changes
Sudarshan Pharma Industries Limited Announces Resignation of Mr. Dharam Jilka from the Position of Chief Financial Officer with Effect from September 15, 2023
Sudarshan Industries Limited Announces Intimation for Incorporation of A Subsidiary Company
Sudarshan Pharma Industries Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Sudarshan Pharma Industries Limited signed a definitive agreement to acquire Ratna Lifesciences Pvt Ltd for INR 55 million.
Sudarshan Pharma Industries to Consider Acquisition of Ratna Lifesciences as Unit
Sudarshan Pharma Industries Limited Recommends Dividend for the Financial Year 2022-23, Payable on and from September 05, 2023
Sudarshan Pharma Industries Limited Appoints Mr. Rushabh P Patil as Additional Director
Sudarshan Pharma Industries Limited Announces Resignation of RAJESH CHANDRAKUMAR HEDAOO as Director
Sudarshan Pharma Industries Limited has completed an IPO in the amount of INR 501.072 million.
Sudarshan Pharma Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Sudarshan Pharma Industries Limited has filed an IPO.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. SUDARSHAN Aktie
  4. Nachrichten Sudarshan Pharma Industries Limited
  5. Andere Sprachen